Skeletal development: insights from targeting the mouse genome
- 1 August 2003
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 362 (9383) , 560-569
- https://doi.org/10.1016/s0140-6736(03)14119-0
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Activation of Transforming Growth Factor β in Chondrocytes Undergoing Endochondral OssificationJournal of Bone and Mineral Research, 2001
- Derivation of the mammalian skull vaultJournal of Anatomy, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3Nature Genetics, 1996
- Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone.Genes & Development, 1995
- A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasiaNature Genetics, 1995
- A Constitutively Active Mutant PTH-PTHrP Receptor in Jansen-Type Metaphyseal ChondrodysplasiaScience, 1995
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995
- Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related geneNature, 1994
- Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain.The Journal of cell biology, 1992